In summary, in this short review, we briefly commented on the nature of some biomarkers obtained from fluid samples, mainly CSF and plasma of AD patients, and on AD diagnosis using imaging techniques, which are based on the detection of the two major hallmarks of AD, namely amyloid (senile plaques) and tau (neurofibrillary tangles) aggregates. This evidence concerns the gene MAPT and Alzheimer disease.